Introduction
Kidney transplantation is the preferred treatment for end-stage renal disease because it provides better quality of life and longer life expectancy compared to dialysis. (1,2) As patients with high panel reactive antibody (PRA) levels represent a growing group on transplantation waiting lists, determining PRA sensitization is important.
Sensitization is the result of a series of events that occur after the immune system encounters antigenic proteins, resulting in permanent B lymphocyte memory and a strong humoral response upon repeat encounter. In order to develop anti-HLA antibodies, an individual must be introduced to foreign HLA antigens. This encounter may occur during the course of a previous transplantation, full blood transfusion, or (3) (4) (5) 6) In the present study, we aimed to determine the antibody profiles of patients with chronic kidney disease who were on the active transplantation waiting list and tested positive for anti-HLA antibodies in HLA class I and II screening.
Materials and Methods
Demographic Characteristics of the Patient Group: The study group comprised 40 patients who were assessed in the Atatürk University Medical Biology Tissue Typing Laboratory due to chronic kidney disease and had positive PRA (class I and/or class II PRA) screening test between 2012 and 2017. These patients were evaluated using SAB assay. The patients' demographic data are shown in (Table 1 
Results
The patient sera that were positive in PRA class I and II screening were used to identify anti-HLA antibodies. Anti-HLA antibodies were detected in a total of 40 patients. Class I and/or class II PRA sensitivity rates and class I/II antibodies were determined in these patients. The detected antibodies are shown in (Table 2 ) and (Figures 1 and 2) . The most frequent class I anti-HLA antibodies were B07 (8.7%), A02 (8%), and A24 (8%), while the most frequent class II anti-HLA antibodies were DR11 (11.6%), DR01 (11.6%), and DQ03 (16.7%). Data Analysis: Categorical data were expressed as n (%). PRA positivity rates were analyzed by frequency analysis. Statistical analysis of the obtained data was performed using SPSS 17.0 SPSS,
Discussion
Anti-HLA antibodies can develop following pregnancy, blood transfusion, or transplantation. The presence of antibodies against donor HLA antigens prior to transplantation is an important factor in graft survival in organ transplantation. (17) The present study reports the allele frequencies of A*02, A*24, B*07, DQ*03, DR*11 of the HLA-B and HLADR-DQ locus antigens. We also identified antibodies against A*68, B*15, B*48, DR*01, DR*07, and DR*16 antigens. The results of our study are compatible with previous reports of HLA allele frequencies in the Turkish population. We believe that the discrepancies with other studies are due to differences in antigenicity.
In light of all of these studies, we again emphasize the importance of immunological monitoring prior to kidney transplantation to recognize the development of anti-HLA antibodies.
